- Our Story
- Our Methods
- Quality Improvement
- Health Systems Strengthening
- Social and Behavior Change
- Research and Evaluation
- Education
- Global Health Security
- HIV and AIDS
- Human Resources for Health (HRH)
- Malaria
- Maternal, Newborn, and Child Health
- Noncommunicable Diseases
- Nutrition
- Reproductive Health and Family Planning
- Tuberculosis
- Vulnerable Children and Families
- Water, Sanitation, and Hygiene
- Our Projects
- Our News
- Join Our Team
Costing of Cryptococcal Screening and Treatment for National Implementation
Overview
The project’s goal is to provide technical assistance to the Eswatini National AIDS Programme (ENAP) to support the initial roll-out and implementation of Cryptococcal Antigen (CrAg) screening and TB LAM testing as part of a package of care for People Living with HIV (PLHIV) presenting to care with advanced HIV disease.
The Challenge
The 2017 WHO Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy and the 2018 Eswatini Integrated HIV management guidelines recommend CrAg screening and TB LAM testing as part of a package of care for people living with HIV (PLHIV) presenting to care with advanced HIV disease. For the roll-out of these services at select hospitals, the CDC Foundation is supporting the Kingdom of Eswatini in the procurement of generic fluconazole for the first year of implementation. URC will oversee procurement funding allocation and provide technical assistance through the rollout to ensure a strong foundation is laid for national provision of these services.
Objectives
URC is working closely with the Ministry of Health and other stakeholders to build ENAP capacity, facilitate training of health providers at chosen health facilities for initial provision of CrAG screening and TB LAM testing, and implement enhanced monitoring and evaluation of the impact of the interventions at the 16 priority sites. Project objectives include:
- To provide technical support to ENAP in the scale-up of advanced HIV disease management in 16 selected facilities of the Kingdom of Eswatini
- To scale up CrAg screening and treatment in 16 selected facilities
- To scale up TB LAM screening and treatment in 16 selected facilities
- To conduct an implementation study on the impact of CrAg and TB LAM screening and treatment in Advanced HIV Disease
Duration
2018 to 2021
Funders
CDC Foundation
Regions/ Countries